
Study on first responders and health care workers shows 80 % effectiveness after just one shot of Covid-19 vaccine
感谢您选择 Automatic Translation。目前,我们提供从英语到法语和德语的翻译,不久的将来还会增加更多翻译语言。请注意,这些翻译是由第三方人工智能软件服务生成的。虽然我们发现这些翻译大部分都是正确的,但并非每种情况下都完美无缺。为确保您阅读的信息正确无误,请参考英文原文。如果您发现翻译中有错误,希望引起我们的注意,请告诉我们,这将对我们大有帮助。我们一旦发现任何文字或章节有误,都会及时更正。如有任何翻译错误,请及时与我们的网站管理员联系。
According to a new US study, COVID-19 vaccines developed by Pfizer with BioNTech and Moderna reduced the risk of infection by 80 per cent after only one shot.
This result was found after two weeks or more after the first out of two injections. After the second injection, the effectiveness increased to 95 %.
This is according to data from a real-world study of vaccinated U.S. health-care personnel and first responders released on Monday March 29th.
The study was conducted by the U.S. Centers for Disease Control and Prevention (CDC). They attempted to evaluate the vaccines' ability to protect against infection, including infections that did not cause symptoms.
"This is very reassuring news," said the CDC's Mark Thompson, who leads the study. "We have a vaccine that's working very well."
The study researched the effectiveness of the mRNA vaccines on 3,950 participants in six US states during 13 weeks from December 14, 2020 to March 13, 2021.
Out of the almost 4000 participants, there were 205 infections, with the vast majority (161 cases) in the unvaccinated control group.
Of the 44 cases in the vaccinated group, the CDC said roughly 3/4 (33 cases) were in people who were exposed before the first shot had become fully effective (within two weeks of the first shot).
No one in the study died, and only two were hospitalized.
"The authorized mRNA COVID-19 vaccines provided early, substantial real-world protection against infection for our nation's health-care personnel, first responders, and other frontline essential workers," CDC Director Rochelle Walensky said in a statement.
About two-thirds of the participants who were vaccinated got Pfizer shots, one-third got Moderna and five got the newest shot from Johnson & Johnson. The study was done in Miami; Duluth, Minnesota; Portland, Oregon; Temple, Texas; Salt Lake City; and Phoenix and other areas in Arizona.
With